<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mrj</journal-id><journal-title-group><journal-title xml:lang="ru">Современная ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Modern Rheumatology Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1996-7012</issn><issn pub-type="epub">2310-158X</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1996-7012-2011-689</article-id><article-id custom-type="elpub" pub-id-type="custom">mrj-374</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Что нам дает изучениестатистики продаж нестероидныхпротивовоспалительных препаратовв Российской Федерации?</article-title><trans-title-group xml:lang="en"><trans-title>What does a study of nonsteroidal anti-inflammatory drug sales statistics give the Russian Federation?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Барскова</surname><given-names>В. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Barskova</surname><given-names>Viktoriya Georgievna</given-names></name></name-alternatives><email xlink:type="simple">barskova@irramn.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Барскова</surname><given-names>В. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Barskova</surname><given-names>Viktoria Georgiyevna</given-names></name></name-alternatives><email xlink:type="simple">barskova@irramn.ru</email></contrib></contrib-group><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>16</day><month>09</month><year>2011</year></pub-date><volume>5</volume><issue>3</issue><issue-title>№3 (2011)</issue-title><fpage>68</fpage><lpage>73</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Барскова В.Г., Барскова В.Г., 2011</copyright-statement><copyright-year>2011</copyright-year><copyright-holder xml:lang="ru">Барскова В.Г., Барскова В.Г.</copyright-holder><copyright-holder xml:lang="en">Barskova V.G., Barskova V.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://mrj.ima-press.net/mrj/article/view/374">https://mrj.ima-press.net/mrj/article/view/374</self-uri><abstract><p>В статье проанализированы данные о продажах нестероидных противовоспалительных препаратов в Российской Федерации, полученные «Фармэкспертом». Ибупрофен, кеторолак, диклофенак и нимесулид являются лидерами продаж. Рассматриваются возможные причины популярности ряда препаратов, а также целесообразность применения внутримышечных форм. Приведены данные бюллетеня ВОЗ о показаниях и противопоказаниях к использованию инъекционных форм.</p></abstract><trans-abstract xml:lang="en"><p>The paper analyzes the data obtained by Pharmexpert on the sales of nonsteroidal anti-inflammatory drugs in the Russian Federation. Ibuprofen, ketorolac, diclofenac, and nimesulide are sales leaders. Possible reasons for the popularity of a number of medications and whether it is expedient to use intramuscular formulations are considered. The WHO data on indi-cations for and contraindications to the use of injectable dosage form are given.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>нестероидные противовоспалительные препараты</kwd><kwd>статистика продаж:</kwd></kwd-group><kwd-group xml:lang="en"><kwd>nonsteroidal anti-inflammatory drugs</kwd><kwd>sales statistics</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
